Bingshan Li, PhD, is a Professor in the Department of Molecular Physiology and Biophysics at Vanderbilt University School of Medicine. His research focuses on computational and statistical genomics, bioinformatics, cancer genomics, complex diseases, and the genetics of psychiatric disorders. He leads studies integrating multi-omics data to identify genetic and epigenetic mechanisms underlying diseases such as Alzheimer’s, breast cancer, and schizophrenia. Specializes in multi-ancestry genomic studies, particularly in African and Asian populations. Develops computational tools for drug repurposing and risk prediction using AI and machine learning. Conducts translational research on circulating tumor cells and methylation biomarkers in cancer progression. His work bridges basic science and clinical applications, emphasizing precision medicine and population health disparities. Recent efforts include leveraging electronic health records and AI to predict disease progression and repurpose drugs for Alzheimer’s. Publications span over 15 years, with a focus on cancer genetics, neurodegenerative diseases, and computational methodologies. No scientific awards were explicitly listed in the provided text.
